Patents by Inventor Masanao Kikukawa

Masanao Kikukawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7544361
    Abstract: A heteropentamer composed of a fusion monomer (32) comprising a fusion protein of an antigenic amino acid sequence and an amino acid sequence of a monomer of a mucous membrane-binding protein and a nonfusion monomer (20) of an amino acid sequence of a monomer of a mucous membrane-binding protein. A homopentamer composed of a fusion monomer including a fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a monomer of a mucous membrane-binding protein. These heteropentamer and the homopentamer can be used as a vaccine.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: June 9, 2009
    Assignees: Advanced Medical Biological Science Institute Co. Ltd., University of the Ryukyus
    Inventors: Takeshi Arakawa, Masanao Kikukawa, Isao Shimabukuro, Masayuki Tadano, Yasunobu Matsumoto, Naotoshi Tsuji, Yoshiya Sato
  • Publication number: 20060246087
    Abstract: A heteropentamer composed of a fusion monomer (32) comprising a fusion protein of an antigenic amino acid sequence and an amino acid sequence of a monomer of a mucous membrane-binding protein and a nonfusion monomer (20) of an amino acid sequence of a monomer of a mucous membrane-binding protein. A homopentamer composed of a fusion monomer including a fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a monomer of a mucous membrane-binding protein. These heteropentamer and the homopentamer can be used as a vaccine.
    Type: Application
    Filed: July 23, 2004
    Publication date: November 2, 2006
    Applicants: ADVANCED MEDICAL BIO. SCIENCE INSTITUTE CO.LTD., UNIVERSITY OF THE RYUKYUS
    Inventors: Takeshi Arakawa, Masanao Kikukawa, Isao Shimabukuro, Masayuki Tadano, Yasunobu Matsumoto, Naotoshi Tsuji, Yoshiya Sato
  • Patent number: 6773913
    Abstract: In a vector purification device, bacteria containing vectors are cultured in a culture medium in a culture tank, the culture medium is concentrated by filtration with a first TFF film, and the concentrated culture medium is replaced with a buffer solution by filtering a mixture of the culture medium and the buffer solution by the TFF film while supplying the buffer solution from a buffer tank. The bacteria subjected to bacteriolysis by an alkali solution supplied from an alkali tank are passed through a second TFF film to remove undesired substances. Since the TFF films are used in place of a centrifugal separator for concentration or the like, a series of operations can be carried out continuously in a closed system. Further, a crudely purified vector solution is treated with a surfactant to separate vector DNAs from endotoxins as separate layers, and the endotoxins are removed.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: August 10, 2004
    Assignees: Advanced Medical Biological Science Institute Co., Ltd.
    Inventors: Sakae Arakaki, Masaru Nagamine, Masanao Kikukawa
  • Publication number: 20020127704
    Abstract: In a vector purification device, bacteria containing vectors are cultured in a culture medium in a culture tank, the culture medium is concentrated by filtration with a first TFF film, and the concentrated culture medium is replaced with a buffer solution by filtering a mixture of the culture medium and the buffer solution by the TFF film while supplying the buffer solution from a buffer tank. The bacteria subjected to bacteriolysis by an alkali solution supplied from an alkali tank are passed through a second TFF film to remove undesired substances. Since the TFF films are used in place of a centrifugal separator for concentration or the like, a series of operations can be carried out continuously in a closed system. Further, a crudely purified vector solution is treated with a surfactant to separate vector DNAs from endotoxins as separate layers, and the endotoxins are removed.
    Type: Application
    Filed: September 28, 2001
    Publication date: September 12, 2002
    Applicant: SAKAE ARAKAKI
    Inventors: Sakae Arakaki, Masaru Nagamine, Masanao Kikukawa